| 6-OHDA | 6-Hydroxydopamine |
| HSP70 | 70 kilodalton heat shock proteins |
| AD | Alzheimer’s disease |
| AMPK | AMP-activated protein kinase |
| AS | Ankylosing spondylitis |
| ADB | Anxiety and depression-like behavior |
| ApoE | Apolipoprotein E |
| Bcl-2 | B-cell lymphoma-2 |
| Bax | Bcl-2-associated X protein |
| BPA | Brachial plexus avulsion |
| BP | Blood pressure |
| BDNF | Brain-derived neurotrophic factor |
| BrdU | Bromodeoxyuridine |
| CREB | cAMP response element-binding protein |
| cTnI | Cardiac troponin I |
| CV | Cardiovascular |
| Cas-3 | Caspase-3 |
| CSF | Cerebrospinal fluid |
| CHF | Chronic heart failure |
| CC16 | Clara cell protein |
| CWS | Cold-water swimming |
| CIA | Collagen-induced arthritis |
| CuNP | Copper nanoparticles |
| CRP | C-reactive protein |
| CKMB | Creatine kinase MB |
| cAMP | Cyclic adenosine monophosphate |
| DCM | Diabetic cardiomyopathy |
| DPN | Diarylpropionitrile |
| DBPs | Disinfection by-products |
| DA | Dopamine |
| DR2 | Dopamine type 2 receptor |
| EA | Electroacupuncture |
| eNOS | Endothelial nitric oxide synthase |
| eWAT | Epididymal white adipose tissue |
| EMT | Epithelial-mesenchymal transition |
| EXE | Exercise |
| EAE | Experimental autoimmune encephalomyelitis |
| FBG | Fasting blood glucose |
| FATP-4 | Fatty acid transport protein 4 |
| FNDC5 | Fibronectin type III domain-containing protein 5 |
| FeNO | Fractional exhaled nitric oxide |
| FED | Fructose-enriched diet |
| GFAP | Glial fibrillary acidic protein |
| GLUT4 | Glucose transporter type 4 |
| GR | Glutathione reductase |
| GSH | Glutathione |
| GSK-3β | Glycogen synthase kinase-3 beta |
| HRR | Heart rate reserve |
| HRV | Heart rate variability |
| HDL | High-density lipoprotein |
| HFD | High-fat diet |
| HIIT | High-intensity interval training |
| HS | High-sodium |
| HDAC | Histone deacetylase |
| HDAC3 | Histone deacetylase 3 |
| HOMA-IR | Homeostatic model assessment of insulin resistance index |
| IgA | Immunoglobulin A |
| iNOS | Inducible nitric oxide synthase |
| I-κB | Inhibitor of kappa B |
| IR | Insulin resistance |
| IGF-1 | Insulin-like Growth Factor-1 |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin-1 beta |
| IRAK1 | Interleukin-1 receptor-associated kinase 1 |
| IL-10 | Interleukin-10 |
| IL-2 | Interleukin-2 |
| IL-6 | Interleukin-6 |
| IL-4 | interleukin-4 |
| ICV | Intracerebroventricular |
| ISO | Isoproterenol |
| LDH | Lactate dehydrogenase |
| LDL | Low-density lipoprotein |
| MΦ | Macrophages |
| MDA | Malondialdehyde |
| MMP-9 | Matrix metalloproteinase-9 |
| MMP-13 | Matrix metalloproteinase-13 |
| VO2max | Maximal oxygen uptake |
| MET | Metformin |
| MPTP | Mitochondrial permeability transition pore |
| MCP-1 | Monocyte chemotactic protein-1 |
| MS | Multiple sclerosis |
| MI | Myocardial infarction |
| NAC | N-acetylcysteine |
| NCAM | Neural cell adhesion molecule |
| NeuN | Neuronal nuclei |
| NAD | Nicotinamide adenine dinucleotide |
| NO | Nitric oxide |
| NAFLD | Nonalcoholic fatty liver disease |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| ND | Normal diet |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NF-κB | Nuclear factor kappa light-chain-enhancer of activated B lymphocytes |
| NOD | Non-obese diabetic |
| NLRP1 | NLR family pyrin domain containing 1 |
| NLRP3 | NLR family pyrin domain containing 3 |
| OA | Osteoarthritis |
| OVX | Ovariectomized |
| OS | Oxidative stress |
| PD | Parkinson’s disease |
| PLIN2 | Perilipin-2 |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PPAR-α | Peroxisome proliferator-activated receptor alpha |
| PTX3 | Pentraxin 3 |
| PI3K | Phosphoinositide 3-kinase |
| PBMT | Photobiomodulation therapy |
| pIgR | Polymeric immunoglobulin receptor |
| PSD95 | Postsynaptic density 95 |
| PFN1 | Profilin-1 |
| PGC-1α | Proliferator-activated receptor gamma coactivator-1 alpha |
| PPT | Propyl pyrazole triol |
| Akt | Protein kinase B |
| RBC | Red blood cell |
| ROS | Reactive oxygen species |
| RANKL | Receptor activator of nuclear factor kappa-Β ligand |
| RVH | Renovascular hypertension |
| RA | Rheumatoid arthritis |
| sIgA | Secretory immunoglobulin A |
| SCD1 | Severe combined immunodeficiency 1 |
| SG | Sebaceous gland |
| SEMA3A | Semaphorin 3A |
| SS | Serotonergic system |
| SIRT1 | Sirtuin 1 |
| SCRI | Skibinski’s cardio-respiratory index |
| STZ | Streptozotocin |
| SOD | Superoxide dismutase |
| ST | Swimming training |
| SNS | Sympathetic nervous system |
| sWAT | Substance white adipose tissue |
| SP-D | Surfactant protein D |
| SBP | Systolic blood pressure |
| TRAF6 | TNF receptor-associated factor 6 |
| TLR-4 | Toll-like receptor 4 |
| TCA | Total antioxidant capacity |
| TNF-α | Tumor necrosis factor alpha |
| T1D | Type 1 diabetes |
| T2D | Type 2 diabetes |
| T2DM | Type 2 diabetes mellitus |
| VEGF | Vascular endothelial growth factor |
| ZDF | Zucker diabetic fatty |
| α7nAChR | α7nicotinic acetylcholine receptor |
| Aβ | β-Amyloid peptide |